STAT

Senate health committee hosts opioid hearing with a single witness: a journalist

In an unusual move, the Senate health committee called just one witness — a journalist — to its hearing on the opioid crisis.

WASHINGTON — In its second hearing on the country’s raging drug crisis since President Trump directed the Department of Health and Human Services to declare the matter a public health emergency in October, the Senate health committee called a hearing with a single witness: a journalist.

Such hearings conventionally spotlight high-profile government officials and career advocates with deep expertise in a subject. Every hearing this

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks